
Tuesday, 12 external healthcare professionals joined on a panel convened by the US Centers for Disease Control and Prevention (CDC) to discuss the usage of Novavax’s Covid-19 vaccine, which was recently emergency authorized by the US Food and Drug Administration (FDA), Bloomberg News reports.
With a unanimous vote backing the vaccine, dubbed Adjuvanted, and the signature of CDC Director Rochelle Walensky, the US now has an additional weapons in its arsenal to combat Covid-19.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app